New drug eRapa could slow polyps in inherited colon cancer condition
Disease control
Recruiting now
This study tests if the drug eRapa can slow disease progression in adults with Familial Adenomatous Polyposis (FAP), a condition that causes many polyps in the gut and raises cancer risk. About 168 participants will take eRapa or a placebo daily every other week. Researchers will…
Phase: PHASE3 • Sponsor: Rapamycin Holdings Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC